Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S BARTLETT

Showing results (251-260 of 386) with videos related to

Pageof 39
Sort By:
Oncotarget|April 9, 2016
A four gene signature of chromosome instability (CIN4) predicts for benefit from taxanes in the NCIC-CTG MA21 clinical trialMelanie Spears, Nicola Lyttle, Alister D'Costa, et al.
International Journal of Radiation Oncology, Biology, Physics|December 27, 2011
Impact of screening and risk factors for local recurrence and survival after conservative surgery and radiotherapy for early breast cancer: results from a large series with long-term follow-upIan H Kunkler, Gillian R Kerr, Jeremy S Thomas, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1993
Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeastsR A Fromtling, J N Galgiani, M A Pfaller, et al.
The Journal of Eukaryotic Microbiology|September 1, 1996
Prevalence of various Pneumocystis carinii sp. f. hominis types in different geographical locationsC H Lee, J J Lu, X Tang, et al.
BMC Genomics|February 26, 2010
Correcting for intra-experiment variation in Illumina BeadChip data is necessary to generate robust gene-expression profilesRobert R Kitchen, Vicky S Sabine, Andrew H Sims, et al.
Histopathology|May 13, 2010
A UK NEQAS ICC and ISH multicentre study using the Kreatech Poseidon HER2 FISH probe: intersite variation can be rigorously controlled using FISHJohn M S Bartlett, Fiona M Campbell, Merdol Ibrahim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 11, 2019
Breast Cancer Index and prediction of benefit from extended endocrine therapy in breast cancer patients treated in the Adjuvant Tamoxifen-To Offer More? (aTTom) trialJ M S Bartlett, D C Sgroi, K Treuner, et al.
Journal of Clinical Microbiology|October 8, 1997
Detection of Pneumocystis carinii DNA in air samples: likely environmental risk to susceptible personsM S Bartlett, S H Vermund, R Jacobs, et al.
Plos One|January 10, 2013
PIK3CA genotype and a PIK3CA mutation-related gene signature and response to everolimus and letrozole in estrogen receptor positive breast cancerSherene Loi, Stefan Michiels, Jose Baselga, et al.
The Journal of Infectious Diseases|November 17, 1998
Sequence polymorphisms in the Pneumocystis carinii cytochrome b gene and their association with atovaquone prophylaxis failureD J Walker, A E Wakefield, M N Dohn, et al.
Pageof 39

Showing results (251-260 of 386) with videos related to

Sort By:
Pageof 39
Oncotarget|April 9, 2016
A four gene signature of chromosome instability (CIN4) predicts for benefit from taxanes in the NCIC-CTG MA21 clinical trialMelanie Spears, Nicola Lyttle, Alister D'Costa, et al.
International Journal of Radiation Oncology, Biology, Physics|December 27, 2011
Impact of screening and risk factors for local recurrence and survival after conservative surgery and radiotherapy for early breast cancer: results from a large series with long-term follow-upIan H Kunkler, Gillian R Kerr, Jeremy S Thomas, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1993
Multicenter evaluation of a broth macrodilution antifungal susceptibility test for yeastsR A Fromtling, J N Galgiani, M A Pfaller, et al.
The Journal of Eukaryotic Microbiology|September 1, 1996
Prevalence of various Pneumocystis carinii sp. f. hominis types in different geographical locationsC H Lee, J J Lu, X Tang, et al.
BMC Genomics|February 26, 2010
Correcting for intra-experiment variation in Illumina BeadChip data is necessary to generate robust gene-expression profilesRobert R Kitchen, Vicky S Sabine, Andrew H Sims, et al.
Histopathology|May 13, 2010
A UK NEQAS ICC and ISH multicentre study using the Kreatech Poseidon HER2 FISH probe: intersite variation can be rigorously controlled using FISHJohn M S Bartlett, Fiona M Campbell, Merdol Ibrahim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 11, 2019
Breast Cancer Index and prediction of benefit from extended endocrine therapy in breast cancer patients treated in the Adjuvant Tamoxifen-To Offer More? (aTTom) trialJ M S Bartlett, D C Sgroi, K Treuner, et al.
Journal of Clinical Microbiology|October 8, 1997
Detection of Pneumocystis carinii DNA in air samples: likely environmental risk to susceptible personsM S Bartlett, S H Vermund, R Jacobs, et al.
Plos One|January 10, 2013
PIK3CA genotype and a PIK3CA mutation-related gene signature and response to everolimus and letrozole in estrogen receptor positive breast cancerSherene Loi, Stefan Michiels, Jose Baselga, et al.
The Journal of Infectious Diseases|November 17, 1998
Sequence polymorphisms in the Pneumocystis carinii cytochrome b gene and their association with atovaquone prophylaxis failureD J Walker, A E Wakefield, M N Dohn, et al.
Pageof 39